Home
>
National Drug Code (NDC)
>
RISPERDAL M-TAB
RISPERDAL M-TAB - 50458-395-30 - (risperidone)
Drug Information of RISPERDAL M-TAB
| Product NDC: | 50458-395 |
| Proprietary Name: | RISPERDAL M-TAB |
| Non Proprietary Name: | risperidone |
| Active Ingredient(s): | .5 mg/1 & nbsp; risperidone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of RISPERDAL M-TAB
| Product NDC: | 50458-395 |
| Labeler Name: | Janssen Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021444 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20030402 |
Package Information of RISPERDAL M-TAB
| Package NDC: | 50458-395-30 |
| Package Description: | 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (50458-395-30) |
NDC Information of RISPERDAL M-TAB
| NDC Code | 50458-395-30 |
| Proprietary Name | RISPERDAL M-TAB |
| Package Description | 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (50458-395-30) |
| Product NDC | 50458-395 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | risperidone |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20030402 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Pharmaceuticals, Inc. |
| Substance Name | RISPERIDONE |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |
